Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Efavirenz/indinavir combination shows efficacy in phase II

Sep. 18, 1997

GEM-92 enters clinical trials for AIDS

Sep. 18, 1997

AIDS rate increases among women

Sep. 17, 1997

Clinical results reported for protease inhibitor/nucleoside analogue combination

Sep. 12, 1997

Clinical evaluation planned for anti-HIV compound with novel mechanism of action

Sep. 8, 1997

Triangle completes acquisition of Avid, rights to DMP-450

Sep. 8, 1997

Zerit receives E.U. approval

Aug. 27, 1997

Second gene discovered that delays AIDS

Aug. 22, 1997

HIV-O licensed to Abbott

Aug. 22, 1997

Efficacy of long-term treatment with dronabinol for AIDS-related anorexia

Aug. 19, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...